Is tolerance induction the answer to adolescent non-adherence?

被引:19
作者
Dhanireddy, KK
Maniscalco, J
Kirk, AD
机构
[1] NIDDK, Transplantat Branch, NIH, US Dept Hlth & Human Serv, Bethesda, MD USA
[2] Georgetown Univ, Med Ctr, Dept Surg, Washington, DC 20007 USA
[3] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Dept Pediat, Washington, DC USA
关键词
transplantation tolerance; organ transplantation; adolescent; patient non-adherence; chimerism; costimulation blockade; lymphocyte depletion;
D O I
10.1111/j.1399-3046.2005.00285.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
By definition, tolerance will eliminate the problem of adolescent medication non-adherence. Although adolescents' propensity toward non-adherence makes them at first glance to be particularly attractive candidates for tolerance trials, there are also immunologic, psychosocial and ethical barriers that temper enthusiasm for their inclusion at present. Limits in emotional and cognitive maturity are combined during the teenage years with adult-like immunologic maturity to lessen the potential for successful implementation of tolerance and near tolerance strategies. Alternatively, an interval step to tolerance in adolescents is to eliminate the medications most likely contributing to non-adherence through harsh side effects such as steroids and calcineurin inhibitors. This manuscript will review the general topic of transplantation tolerance with specific attention given to the application of pro-tolerant therapies in adolescent recipients.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 61 条
[1]  
Abecassis M, 2000, JAMA-J AM MED ASSOC, V284, P2919
[2]   Heterologous immunity provides a potent barrier to transplantation tolerance [J].
Adams, AB ;
Williams, MA ;
Jones, TR ;
Shirasugi, N ;
Durham, MM ;
Kaech, SM ;
Wherry, EJ ;
Onami, T ;
Lanier, JG ;
Kokko, KE ;
Pearson, TC ;
Ahmed, R ;
Larsen, CP .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) :1887-1895
[3]   Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates [J].
Adams, AB ;
Shirasugi, N ;
Durham, MM ;
Strobert, E ;
Anderson, D ;
Rees, P ;
Cowan, S ;
Xu, HY ;
Blinder, Y ;
Cheung, M ;
Hollenbaugh, D ;
Kenyon, NS ;
Pearson, TC ;
Larsen, CP .
DIABETES, 2002, 51 (02) :265-270
[4]   Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients [J].
Ault, BH ;
Honaker, MR ;
Gaber, AO ;
Jones, DP ;
Duhart, BT ;
Powell, SL ;
Hays, DW ;
Wyatt, RJ .
PEDIATRIC NEPHROLOGY, 2002, 17 (10) :815-818
[5]   ACTIVELY ACQUIRED TOLERANCE OF FOREIGN CELLS [J].
BILLINGHAM, RE ;
BRENT, L ;
MEDAWAR, PB .
NATURE, 1953, 172 (4379) :603-606
[6]   Long-term venous complications after full-size and segmental pediatric liver transplantation [J].
Buell, JF ;
Funaki, B ;
Cronin, DC ;
Yoshida, A ;
Perlman, MK ;
Lorenz, J ;
Kelly, S ;
Brady, L ;
Leef, JA ;
Millis, JM .
ANNALS OF SURGERY, 2002, 236 (05) :658-666
[7]   Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients [J].
Calne, R ;
Moffatt, SD ;
Friend, PJ ;
Jamieson, NV ;
Bradley, JA ;
Hale, G ;
Firth, J ;
Bradley, J ;
Smith, KGC ;
Waldmann, M .
TRANSPLANTATION, 1999, 68 (10) :1613-1616
[8]   Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients [J].
Calne, R ;
Friend, P ;
Moffatt, S ;
Bradley, A ;
Hale, G ;
Firth, J ;
Bradley, J ;
Smith, K ;
Waldmann, H .
LANCET, 1998, 351 (9117) :1701-1702
[9]  
Cecka J M, 1997, Pediatr Transplant, V1, P55
[10]   Mixed chimerism and transplantation tolerance [J].
Cosimi, AB ;
Sachs, DH .
TRANSPLANTATION, 2004, 77 (06) :943-946